People · Operator
Named in public records as an officer, director or promoter · active 2021–2026 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Falkbuilt Ltd. | — | Other | Series B | $85.2M | $11.2M | 2021 |
| Ordaos, Inc. | — | Biotechnology | Series A | $16.8M | $1.3M | 2022 |
| Falkbuilt Ltd. | Director | Other | Seed | $1.5M | $3.0M | 2026 |
| Echo Ltd. | — | Other | Pre-Seed | $379K | $1.2M | 2022 |
David Longo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Longo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Yip | 3 | 6 |
| Barrie Loberg | 3 | 4 |
| Mogens Smed | 3 | 4 |
| Steve Essig | 3 | 3 |
| Jackson Farrow | 3 | 3 |
| Noel Strauss | 3 | 3 |
| Kim Augspurger | 2 | 2 |
| Dan McQuade | 2 | 2 |
| Bassem Nassif | 2 | 2 |
| Thom Hinton | 2 | 2 |
| Ron Welch | 2 | 2 |
| Benjamin Britt | 1 | 5 |
| Scott Horner | 1 | 3 |
| James Ramey | 1 | 1 |
| Tom Hinton | 1 | 1 |
| Ulo Palm | 1 | 1 |
| Kim Augsperger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.